C274H175N15O5 — CID 158610385
8-[7-[4-(4,6-diphenylpyrimidin-2-yl)phenyl]spiro[fluorene-9,9'-xanthene]-2-yl]quinoline;8-[7-(2,6-diphenylpyrimidin-4-yl)spiro[fluorene-9,9'-xanthene]-2-yl]-5-phenylquinoline;8-[7-(2,6-diphenylpyrimidin-4-yl)spiro[fluorene-9,9'-xanthene]-2-yl]quinoline;8-[7'-[2-phenyl-6-(4-phenylphenyl)pyrimidin-4-yl]spiro[4a,9a-dihydroxanthene-9,9'-fluorene]-2'-yl]quinoline;7-[(2E,4Z,6E)-7'-[2-phenyl-6-(3-phenylphenyl)pyrimidin-4-yl]spiro[1-benzoxecine-8,9'-fluorene]-2'-yl]quinoline (PubChem CID 158610385) has the molecular formula C274H175N15O5 and a molecular weight of 3757.51 g/mol. Its IUPAC name is 8-[7-[4-(4,6-diphenylpyrimidin-2-yl)phenyl]spiro[fluorene-9,9'-xanthene]-2-yl]quinoline;8-[7-(2,6-diphenylpyrimidin-4-yl)spiro[fluorene-9,9'-xanthene]-2-yl]-5-phenylquinoline;8-[7-(2,6-diphenylpyrimidin-4-yl)spiro[fluorene-9,9'-xanthene]-2-yl]quinoline;8-[7'-[2-phenyl-6-(4-phenylphenyl)pyrimidin-4-yl]spiro[4a,9a-dihydroxanthene-9,9'-fluorene]-2'-yl]quinoline;7-[(2E,4Z,6E)-7'-[2-phenyl-6-(3-phenylphenyl)pyrimidin-4-yl]spiro[1-benzoxecine-8,9'-fluorene]-2'-yl]quinoline.
| Compound Name | 8-[7-[4-(4,6-diphenylpyrimidin-2-yl)phenyl]spiro[fluorene-9,9'-xanthene]-2-yl]quinoline;8-[7-(2,6-diphenylpyrimidin-4-yl)spiro[fluorene-9,9'-xanthene]-2-yl]-5-phenylquinoline;8-[7-(2,6-diphenylpyrimidin-4-yl)spiro[fluorene-9,9'-xanthene]-2-yl]quinoline;8-[7'-[2-phenyl-6-(4-phenylphenyl)pyrimidin-4-yl]spiro[4a,9a-dihydroxanthene-9,9'-fluorene]-2'-yl]quinoline;7-[(2E,4Z,6E)-7'-[2-phenyl-6-(3-phenylphenyl)pyrimidin-4-yl]spiro[1-benzoxecine-8,9'-fluorene]-2'-yl]quinoline |
|---|---|
| PubChem CID | 158610385 |
| Molecular Formula | C274H175N15O5 |
| Molecular Weight | 3757.51 g/mol |
| Exact Mass | 3754.39 |
| IUPAC Name | 8-[7-[4-(4,6-diphenylpyrimidin-2-yl)phenyl]spiro[fluorene-9,9'-xanthene]-2-yl]quinoline;8-[7-(2,6-diphenylpyrimidin-4-yl)spiro[fluorene-9,9'-xanthene]-2-yl]-5-phenylquinoline;8-[7-(2,6-diphenylpyrimidin-4-yl)spiro[fluorene-9,9'-xanthene]-2-yl]quinoline;8-[7'-[2-phenyl-6-(4-phenylphenyl)pyrimidin-4-yl]spiro[4a,9a-dihydroxanthene-9,9'-fluorene]-2'-yl]quinoline;7-[(2E,4Z,6E)-7'-[2-phenyl-6-(3-phenylphenyl)pyrimidin-4-yl]spiro[1-benzoxecine-8,9'-fluorene]-2'-yl]quinoline |
| SMILES | C1=CC2Oc3ccccc3C3(c4cc(-c5cc(-c6ccc(-c7ccccc7)cc6)nc(-c6ccccc6)n5)ccc4-c4ccc(-c5cccc6cccnc56)cc43)C2C=C1.C1=C\C=C\C2(c3ccccc3O/C=C/1)c1cc(-c3ccc4cccnc4c3)ccc1-c1ccc(-c3cc(-c4cccc(-c5ccccc5)c4)nc(-c4ccccc4)n3)cc12.c1ccc(-c2cc(-c3ccc4c(c3)C3(c5ccccc5Oc5ccccc53)c3cc(-c5ccc(-c6ccccc6)c6cccnc56)ccc3-4)nc(-c3ccccc3)n2)cc1.c1ccc(-c2cc(-c3ccc4c(c3)C3(c5ccccc5Oc5ccccc53)c3cc(-c5cccc6cccnc56)ccc3-4)nc(-c3ccccc3)n2)cc1.c1ccc(-c2cc(-c3ccccc3)nc(-c3ccc(-c4ccc5c(c4)C4(c6ccccc6Oc6ccccc64)c4cc(-c6cccc7cccnc67)ccc4-5)cc3)n2)cc1 |
| InChI | InChI=1S/2C56H35N3O.2C56H37N3O.C50H31N3O/c1-4-15-36(16-5-1)41-30-31-42(54-45(41)21-14-32-57-54)39-26-28-43-44-29-27-40(51-35-50(37-17-6-2-7-18-37)58-55(59-51)38-19-8-3-9-20-38)34-49(44)56(48(43)33-39)46-22-10-12-24-52(46)60-53-25-13-11-23-47(53)56;1-3-13-37(14-4-1)50-35-51(38-15-5-2-6-16-38)59-55(58-50)40-26-24-36(25-27-40)41-28-30-44-45-31-29-42(43-19-11-17-39-18-12-32-57-54(39)43)34-49(45)56(48(44)33-41)46-20-7-9-22-52(46)60-53-23-10-8-21-47(53)56;1-3-13-36(14-4-1)37-24-26-38(27-25-37)50-35-51(59-55(58-50)40-15-5-2-6-16-40)42-29-31-45-44-30-28-41(43-19-11-17-39-18-12-32-57-54(39)43)33-48(44)56(49(45)34-42)46-20-7-9-22-52(46)60-53-23-10-8-21-47(53)56;1-2-12-32-60-54-23-10-9-22-48(54)56(30-11-1)49-34-42(43-25-24-39-21-14-31-57-51(39)36-43)26-28-46(49)47-29-27-45(35-50(47)56)53-37-52(58-55(59-53)40-17-7-4-8-18-40)44-20-13-19-41(33-44)38-15-5-3-6-16-38;1-3-13-32(14-4-1)44-31-45(53-49(52-44)34-15-5-2-6-16-34)36-25-27-39-38-26-24-35(37-19-11-17-33-18-12-28-51-48(33)37)29-42(38)50(43(39)30-36)40-20-7-9-22-46(40)54-47-23-10-8-21-41(47)50/h2*1-35H;1-35,46,52H;1-37H;1-31H/b;;;2-1-,30-11+,32-12+; |
| InChIKey | HWTMMSOPMGVZKI-MENIDSOBSA-N |
| XLogP | 66.69 |
| TPSA | 239.50 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 20 |
| Rotatable Bonds | 24 |
| Heavy Atoms | 294 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3757.51 |
| LogP ≤ 5 | 66.69 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 20 |